The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modes of action of anthelmintic drugs
Martin, R. J. (1997) · The Veterinary Journal · doi:10.1016/s1090-0233(05)80005-x · Cited by 538
Research works printed but not linked: 25
- Campbell, 1993, Ivermectin, an antiparasitic agent, Med. Res. Rev., 13, 61, 10.1002/med.2610130103 · doi:10.1002/med.2610130103
- Campbell, 1984, Ivermectin: a review of efficacy and safety, J. Vet. Pharmacol. Ther., 7, 1, 10.1111/j.1365-2885.1984.tb00872.x · DOI · Paper page
- Conrad, 2001, Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1, Toxicology, 156, 81, 10.1016/S0300-483X(00)00354-1 · DOI
- De Silva, 1997, Anthelmintics. A comparative review of their clinical pharmacology, Drugs, 53, 769, 10.2165/00003495-199753050-00004 · DOI
- Didier, 1996, The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor, Anti-Cancer Drugs, 7, 745, 10.1097/00001813-199609000-00005 · DOI
- Eytan, 1999, Mechanism of action of P-glycoprotein in relation to passive membrane permeation, Int. Rev. Cyt., 190, 175, 10.1016/S0074-7696(08)62148-8 · DOI
- Fassler, 1991, Evaluation of the safety of ivermectin administered in a beef-based formulation to ivermectin-sensitive Collies, J. Am. Vet. Med. Assoc., 199, 457, 10.2460/javma.1991.199.04.457 · DOI
- Grobet, 1997, A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle, Nat. Genet., 17, 71, 10.1038/ng0997-71 · DOI · Paper page
- Lankas, 1997, P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity, Toxicol. Appl. Pharmacol., 143, 357, 10.1006/taap.1996.8086 · DOI · Paper page
- Leveille-Webster, 1995, The biology of the P-glycoproteins, J. Membr. Biol., 143, 89, 10.1007/BF00234655 · DOI
- Mealey, 2001, Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene, Pharmacogenetics, 11, 727, 10.1097/00008571-200111000-00012 · DOI · Paper page
- Nobmann, 2001, Ivermectin excretion by isolated functionally intact brain endothelial capillaries, Br. J. Pharmacol., 132, 722, 10.1038/sj.bjp.0703762 · doi:10.1038/sj.bjp.0703762
- Paul, 1987, Clinical observations in Collies given ivermectin orally, Am. J. Vet. Res., 48, 684
- Paul, 1991, Evaluating the safety of administration high doses of a chewable ivermectin tablet to Collies, Vet. Med., 86, 623
- Paul, 2000, Safety of moxidectin in avermectin-sensitive Collies, Am. J. Vet. Res., 61, 482, 10.2460/ajvr.2000.61.482 · DOI
- Pouliot, 1997, Reversal of P-glycoprotein-associated multidrug resistance by ivermectin, Biochem. Pharmacol., 53, 17, 10.1016/S0006-2952(96)00656-9 · DOI · Paper page
- Pulliam, 1985, Investing ivermectin toxicity in Collies, Vet. Med., 33
- Schinkel, 1994, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs, Cell, 77, 491, 10.1016/0092-8674(94)90212-7 · DOI · Paper page
- Schinkel, 1996, P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs, J. Clin. Invest., 97, 2517, 10.1172/JCI118699 · DOI · Paper page
- Sutherland, 1990, Development, pharmacokinetics and mode of action of ivermectin, Acta Leiden, 59, 161
- Tang-Wai, 1995, Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators, Biochemistry, 34, 32, 10.1021/bi00001a005 · doi:10.1021/bi00001a005
- Tranquilli, 1991, Assessment of toxicosis induced by high-dose administration of milbemycin oxime in Collies, Am. J. Vet. Res., 52, 1170, 10.2460/ajvr.1991.52.07.1170 · DOI
- Tsuji, 1998, P-glycoprotein-mediated efflux transport of anticancer drugs at the blood–brain barrier, Ther. Drug Monit., 20, 588, 10.1097/00007691-199810000-00024 · DOI
- Umbenhauer, 1997, Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism, Toxicol. Appl. Pharmacol., 146, 88, 10.1006/taap.1997.8225 · doi:10.1006/taap.1997.8225
- Yamazaki, 2001, In vitro substrate identification studies for P-glycoprotein-mediated transport: species difference and predictability of in vivo results, J. Pharmacol. Exp. Ther., 296, 723
Cited by
Sarkadi, B., Homolya, L., Szakács, G., & Váradi, A. (2006) · Physiological Reviews · doi:10.1152/physrev.00037.2005 · Cited by 726
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 617
ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
Eckford, P. D. W., & Sharom, F. J. (2009) · Chemical Reviews · doi:10.1021/cr9000226 · Cited by 597
Doran, A., Obach, R. S., Smith, B. J., Hosea, N. A., Becker, S., Callegari, E., Chen, C., Chen, X., Choo, E., Cianfrogna, J., et al. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001230 · Cited by 443
Moxidectin and the avermectins: Consanguinity but not identity
Prichard, R., Ménez, C., & Lespine, A. (2012) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2012.04.001 · Cited by 439
Metadata
- Authors
- Roulet, A., Puel, O., Gesta, S., Lepage, J.-F., Drag, M., Soll, M., Alvinerie, M., & Pineau, T.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 460
- Issue
- 2-3
- Pages
- 85-91
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2066112168
- Cited by
- 171
- References
- 1
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. https://app.cochat.ai/papers/10.1016/s0014-2999(02)02955-2
- The paper
- Roulet, A., Puel, O., Gesta, S., Lepage, J.-F., Drag, M., Soll, M., Alvinerie, M., & Pineau, T. (2003). MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. European Journal of Pharmacology. https://doi.org/10.1016/s0014-2999(02)02955-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.